Case Study

Ensuring Uninterrupted Market Presence with Proactive Obsolescence Management and Risk Mitigation

Fostering Operational Excellence and Cost Efficiency for a US-Based Scientific Equipment Manufacturer

Unique bills of material analysed

Legacy products revamped


Annual savings achieved


In the rapidly evolving MedTech landscape, marked by an accelerating shift towards digitisation and personalised healthcare solutions, industry leaders are navigating through various challenges.

A USA based medical technology leader was on a mission to solve their MedTech operational issues stemming from outdated technologies, regulatory compliance, and supply chain issues.

Serving nearly 80 countries, the client specialises in diverse fields such as Life Sciences, Analytical Chemistry, Healthcare, Clinical Diagnostics, Pharma and Bio-Technology. The client partnered with Tata Elxsi to help them transform  MedTech operations stemming from outdated technologies, regulatory compliance, and supply chain issues.

Tata Elxsi had to also help to undertake MedTech product assessment and leverage Value Analysis/Value Engineering (VA/VE) methodologies, ensuring optimal performance at the targeted cost.


Streamlining process for legacy products with limited documentation across diverse business divisions presented a hurdle.

Rapid action was needed to disseminate processes and information across various units managing a wide product range. The absence of standardised processes globally within the organisation resulted in reduced productivity.

To enhance profit margins, low-cost alternative sourcing methods were essential for the legacy devices. 

Developing acceptance criteria in accordance with the IEC 62402:2019 standards, coupled with the goal of achieving cost reductions within a stringent timeframe, presented a significant challenge.


Tata Elxsi provided extraordinary expertise tailored an obsolescence management strategy. It focused on optimising processes for sourcing alternative parts, conducting risk analyses, managing changes, and providing comprehensive reporting to leadership.

By conducting regular assessments of the product line, the team was able to identify potential risks early and develop effective solutions. The use of VA/VE methodologies enabled the proposal and implementation of optimised solutions, ensuring that cost targets were met efficiently, thereby directly addressing the disruptions faced in the client's MedTech operations.



The customised solution implemented by Tata Elxsi brought about transformative operational benefits and cost savings:

  • Executed risk analysis on over 400 unique bills of materials and modernised 30 legacy products with strategic change management, reinforcing the quality across diverse business divisions.
  • Achieved $700k in annual savings through diligent application of Value Analysis/Value Engineering (VA/VE) methodologies that led to cost savings and accelerated project timelines.
  • Proactive risk management and efficient obsolescence tracking ensured uninterrupted production lines.

These measures have substantially strengthened the client's market position in the MedTech industry, showcasing our dedication to fostering operational excellence and cost efficiency

Services rendered

Tata Elxsi

  • Risk Analysis of Bill of Material
  • Alternate component/ Dual source identification and qualification
  • Change Management
  • Project Management
  • VA/VE to reduce/optimise product cost
  • Develop an obsolescence management process as IEC 62402:2019
  • Process Implementation

Contact us to know more →